Aspergillosis Global Clinical Trials Review, H1, 2012

GlobalData, January 2012, Pages: 93

Aspergillosis Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Aspergillosis Global Clinical Trials Review, H2, 2011" provides data on the Aspergillosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aspergillosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aspergillosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Aspergillosis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Aspergillosis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Aspergillosis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Aspergillosis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Aspergillosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Proaparts srl
Clinical Trial Overview of Proaparts srl
Novartis AG
Clinical Trial Overview of Novartis AG
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Postgraduate Institute of Medical Education and Research
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Nagasaki University
Clinical Trial Overview of Nagasaki University
University of Heidelberg
Clinical Trial Overview of University of Heidelberg
Shanghai Jiao Tong University
Clinical Trial Overview of Shanghai Jiao Tong University
Singapore General Hospital
Clinical Trial Overview of Singapore General Hospital
PETHEMA
Clinical Trial Overview of PETHEMA
University Hospital Gasthuisberg
Clinical Trial Overview of University Hospital Gasthuisberg
Umea University
Clinical Trial Overview of Umea University
Peking University
Clinical Trial Overview of Peking University
Australian Centre for Vaccine Development
Clinical Trial Overview of Australian Centre for Vaccine Development
Erasmus MC
Clinical Trial Overview of Erasmus MC
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
Capital Medical University
Clinical Trial Overview of Capital Medical University
University of Cologne
Clinical Trial Overview of University of Cologne
The First Affiliated Hospital of Guangzhou Medical College
Clinical Trial Overview of The First Affiliated Hospital of Guangzhou Medical College
Catholic University of the Sacred Heart
Clinical Trial Overview of Catholic University of the Sacred Heart
University Hospital Inselspital, Berne
Clinical Trial Overview of University Hospital Inselspital, Berne
Universitaire Ziekenhuizen Leuven
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Aspergillosis Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, North America, Top Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, BRIC Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, G7 Countries, 2012-
Aspergillosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Aspergillosis Therapeutics Clinical Trials, E7 Countries, 2012-
Aspergillosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Aspergillosis Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Aspergillosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Aspergillosis Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Aspergillosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Aspergillosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Aspergillosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Aspergillosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Proaparts srl, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki University, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by PETHEMA, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Gasthuisberg, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Australian Centre for Vaccine Development, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Guangzhou Medical College, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Catholic University of the Sacred Heart, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012-
Aspergillosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2012-

List of Figures
Aspergillosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Aspergillosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Aspergillosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Aspergillosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Aspergillosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012-
Aspergillosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Aspergillosis Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Aspergillosis Therapeutics Clinical Trials, G7 Countries (%), 2012-
Aspergillosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Aspergillosis Therapeutics Clinical Trials, E7 Countries (%), 2012-
Aspergillosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Aspergillosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Aspergillosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Aspergillosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Aspergillosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Aspergillosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Aspergillosis - Pipeline Review, H2 2012
• Cholangitis Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Otitis Media Global Clinical Trials Review, H2, 2012
• Strabismus Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Keratitis Global Clinical Trials Review, H2, 2012
• Hemostasis Global Clinical Trials Review, H1, 2013
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Anal Fissure Global Clinical Trials Review, H1, 2013